GlassScriptPhysician profile
Timothy Michael Jordan
NPI 1770824948
$13,109.42
in general payments reported to CMS, 2019-2025
46 companies · $3,400 in 2025
The $3,400 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $785 · 2021: $2,462 · 2022: $1,512 · 2023: $2,264 · 2024: $1,847 · 2025: $3,400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,330 · Travel and Lodging: $1,163 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,330.41 |
| Travel and Lodging | $1,162.68 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,868.14 | 2019-2025 | Triclip, Mitraclip, Xience Skypoint |
| Amgen INC. | $1,295.34 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $1,052.85 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, Watchman Access System |
| Janssen Pharmaceuticals, INC | $994.43 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $935.63 | 2019-2025 | |
| Shockwave Medical, INC | $907.91 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $702.04 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $653.33 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $569.05 | 2019-2025 | Farxiga |
| Novo Nordisk INC | $551.63 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $450.28 | 2021-2024 | Verquvo |
| Amarin Pharma, INC. | $322.35 | 2019-2022 | |
| Esperion Therapeutics, INC. | $231.99 | 2020-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $218.25 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $204.57 | 2020-2023 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $193.88 | 2023-2024 | Rotarexs 6 F X 135 Cm, Crosser Iq |
| E.R. Squibb & Sons, L.L.C. | $182.22 | 2019-2024 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $162.12 | 2024-2025 | Onpattro |
| Actelion Pharmaceuticals US, INC. | $153.67 | 2019-2025 | Opsumit |
| Lexicon Pharmaceuticals, INC. | $134.84 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $134.41 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $123.38 | 2019-2025 | Lifevest |
| Cardiovascular Systems INC. | $114.78 | 2023 | Diamondback Coronary |
| Livanova USA, INC. | $108.71 | 2023 | Lifesparc |
| Ekos Corporation | $104.00 | 2019 | |
| Kestra Medical Technology Services, INC. | $79.96 | 2025 | Assure Wcd |
| Kowa Pharmaceuticals America, INC. | $67.10 | 2020-2023 | Livalo |
| Medtronic, INC. | $61.29 | 2021-2022 | |
| Cardiva Medical, INC. | $51.39 | 2025 | Savvywire, Optowire |
| Corcept Therapeutics | $46.09 | 2025 | Korlym |
| Kiniksa Pharmaceuticals, LTD. | $45.99 | 2021-2022 | |
| Abiomed | $40.51 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $38.66 | 2019-2024 | Evkeeza |
| Biotronik INC. | $30.72 | 2023 | Amvia Edge |
| Angiodynamics, INC. | $30.52 | 2022 | |
| Medtronic Vascular, INC. | $28.12 | 2020 | |
| Daiichi Sankyo INC. | $26.86 | 2024 | Injectafer |
| Biosense Webster, INC. | $26.07 | 2022 | |
| Recor Medical INC | $25.26 | 2024 | Paradise Renal Denervation System |
| Edwards Lifesciences Corporation | $24.76 | 2024 | Sapien 3 Ultra Resilia |
| United Therapeutics Corporation | $22.81 | 2025 | Tyvaso |
| Astellas Pharma US INC | $22.65 | 2021 | |
| Preventice Services, LLC | $22.49 | 2021 | |
| Lilly USA, LLC | $17.75 | 2024 | Mounjaro, Zepbound |
| Kiniksa Pharmaceuticals International, Plc | $16.87 | 2024 | Arcalyst |
| Atricure, INC. | $13.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.